|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income from operations to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Stock-based compensation | |||||
| Equity in net earnings of affiliate | |||||
| Losses (gains) on investments | |||||
| Investment impairment | |||||
| Loss on convertible debt conversion | |||||
| Contingent consideration adjustment | |||||
| Provision for excess and obsolete inventory | |||||
| Amortization | |||||
| Loss (gain) on sale of business | |||||
| Deferred taxes | |||||
| Retirement plan actuarial losses (gains) | |||||
| Loss (gain) on sale of asset | |||||
| Other | |||||
| Changes in operating assets and liabilities, net of businesses acquired: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepayments and other assets | |||||
| Accounts payable and other liabilities | |||||
| Deferred revenue and customer advances | |||||
| Retirement plans contributions | |||||
| Income taxes | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property, plant and equipment | |||||
| Acquisition of businesses, net of cash and cash equivalents acquired | |||||
| Purchase of investment in a business | |||||
| Purchases of marketable securities | |||||
| Issuance of convertible loan | |||||
| Proceeds from the sale of a business, net of cash and cash equivalents sold | |||||
| Proceeds from maturities of marketable securities | |||||
| Proceeds from sales of marketable securities | |||||
| Proceeds from insurance | |||||
| Proceeds from sale of asset | |||||
| Net cash used for investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from borrowings on revolving credit facility | |||||
| Repayments of borrowings on revolving credit facility | |||||
| Dividend payments | |||||
| Repurchase of common stock | |||||
| Payments related to net settlement of employee stock compensation awards | |||||
| Payments of convertible debt principal | |||||
| Issuance of common stock under stock purchase and stock option plans | |||||
| Net cash used for financing activities | |||||
| Effects of exchange rate changes on cash and cash equivalents | |||||
| Decrease increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplementary disclosure of cash flows information: | |||||
| Cash paid for: | |||||
| Interest | |||||
| Income taxes | |||||
| Non-cash investing activities: | |||||
| Capital expenditures incurred but not yet paid: | |||||
Loading...